An Alzheimer’s pill appears to protect some in a high-risk population

(By Jon Hamilton for NPR published October 29, 2025)

In April, the future was looking bleak for an experimental Alzheimer’s drug called valiltramiprosate, or ALZ-801.

Researchers had just released topline results of a study of more than 300 people age 50 or older, who were genetically predisposed to Alzheimer’s. Overall, those who got the drug did no better than those given a placebo. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.